Literature DB >> 24673430

Semaphorin 3A alters endothelial cell immunogenicity by regulating Class II transactivator activity circuits.

Laura Schlahsa1, HaiJiao Zhang, Anja Battermann, Murielle Verboom, Stephan Immenschuh, Britta Eiz-Vesper, Renata Stripecke, Katrin Engelmann, Rainer Blasczyk, Constança Figueiredo.   

Abstract

BACKGROUND: Endothelial cells (ECs) play a pivotal role in the allogeneic immune response upon transplantation. Semaphorin 3A (Sema3A) was implicated in the modulation of EC growth, but its effects on immunogenicity were not previously investigated. STUDY DESIGN AND METHODS: ECs were transduced with a lentiviral vector encoding for the green fluorescence protein (GFP) sequence under the control of a Class II transactivator (CIITA)-dependent promoter. Upon stimulation of nonmodified ECs with recombinant Sema3A protein, mRNA and protein levels of CIITA, HLA-DR, and Sema3A receptors were evaluated. An enzyme-linked immunosorbent assay was developed to quantify Sema3A levels in the sera of kidney-transplanted patients.
RESULTS: Sema3A stimulation of lentiviral vector encoding for the GFP sequence ECs caused a significant up regulation of the transgene expression, indicating an increase in CIITA levels. Stimulation of nonmodified ECs with Sema3A resulted in an up regulation of CIITA expression, which was associated with enhanced HLA-DR levels and an increase in alloreactive CD4+ T-cell proliferation. Sema3A receptor expression was enhanced by CIITA, establishing a positive feedback loop. Higher levels of Sema3A were observed in sera of patients presenting with organ rejection.
CONCLUSION: This study links Sema3A signaling in ECs with increased CIITA levels and higher HLA-DR expression, resulting in CD4+ T-cell activation, which might have important implications for tissue and organ transplantation.
© 2014 AABB.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24673430     DOI: 10.1111/trf.12631

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  4 in total

1.  Responder individuality in red blood cell alloimmunization.

Authors:  Christoph Gassner
Journal:  Transfus Med Hemother       Date:  2014-11-14       Impact factor: 3.747

2.  Semaphorin 3A controls allergic and inflammatory responses in experimental allergic conjunctivitis.

Authors:  Junmi Tanaka; Hideo Tanaka; Nobuhisa Mizuki; Eiichi Nomura; Norihiko Ito; Naoko Nomura; Masayuki Yamane; Tomonobu Hida; Yoshio Goshima; Hiroshi Hatano; Hisashi Nakagawa
Journal:  Int J Ophthalmol       Date:  2015-02-18       Impact factor: 1.779

3.  Development of potent class II transactivator gene delivery systems capable of inducing de novo MHC II expression in human cells, in vitro and ex vivo.

Authors:  M L Palma; P Duangkhae; B Douradinha; I F T Viana; P O Rigato; R Dhalia; R B Mailliard; S M Barratt-Boyes; E J M Nascimento; T M Oshiro; A J da Silva Duarte; E T A Marques
Journal:  Gene Ther       Date:  2017-04-17       Impact factor: 4.184

4.  HLA class II antibodies induce necrotic cell death in human endothelial cells via a lysosomal membrane permeabilization-mediated pathway.

Authors:  Abid Aljabri; Vijith Vijayan; Metodi Stankov; Christoph Nikolin; Constanca Figueiredo; Rainer Blasczyk; Jan Ulrich Becker; Andreas Linkermann; Stephan Immenschuh
Journal:  Cell Death Dis       Date:  2019-03-08       Impact factor: 8.469

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.